{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:16:42Z","timestamp":1790320602997,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jim.2014.06.001","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T06:16:45Z","timestamp":1402381005000},"page":"142-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines"],"prefix":"10.1016","volume":"408","author":[{"given":"Alex-Mikael","family":"Barkoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Guiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Markey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Berbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Mertsola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2014.06.001_bb0005","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1128\/JCM.02036-12","article-title":"Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009","volume":"51","author":"Advani","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2014.06.001_bb0010","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1128\/CVI.00367-12","article-title":"Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland","volume":"19","author":"Barkoff","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2014.06.001_bb0015","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1016\/j.vaccine.2009.07.074","article-title":"First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin","volume":"27","author":"Bouchez","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2014.06.001_bb0020","doi-asserted-by":"crossref","first-page":"e35874","DOI":"10.1371\/journal.pone.0035874","article-title":"Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia","volume":"7","author":"Campbell","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2014.06.001_bb0025","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1128\/JCM.02484-07","article-title":"Is the sequenced Bordetella pertussis strain Tohama I representative of the species?","volume":"46","author":"Caro","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2014.06.001_bb0030","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/01.inf.0000177282.53500.77","article-title":"Resurgence of pertussis in Europe","volume":"24","author":"Celentano","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.jim.2014.06.001_bb0035","doi-asserted-by":"crossref","first-page":"e1003418","DOI":"10.1371\/journal.ppat.1003418","article-title":"Pertussis: challenges today and for the future","volume":"9","author":"Cherry","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jim.2014.06.001_bb0040","doi-asserted-by":"crossref","first-page":"e14183","DOI":"10.1371\/journal.pone.0014183","article-title":"Seroprevalence of pertussis in the Netherlands: evidence for increased circulation of Bordetella pertussis","volume":"5","author":"de Greeff","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2014.06.001_bb0045","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1086\/644733","article-title":"Bordetella pertussis and pertussis vaccines","volume":"49","author":"Guiso","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jim.2014.06.001_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2180-8-162","article-title":"Bordetella pertussis isolates in Finland: serotype and fimbrial expression","volume":"8","author":"Heikkinen","year":"2008","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.jim.2014.06.001_bb0055","doi-asserted-by":"crossref","first-page":"e47635","DOI":"10.1371\/journal.pone.0047635","article-title":"Identification of a CO2 responsive regulon in Bordetella","volume":"7","author":"Hester","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2014.06.001_bb0060","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1016\/j.vaccine.2007.05.039","article-title":"The role of peptide loops of the Bordetella pertussis protein P.69 pertactin in antibody recognition","volume":"25","author":"Hijnen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2014.06.001_bb0065","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.meegid.2011.09.012","article-title":"Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries","volume":"11","author":"Kallonen","year":"2011","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.jim.2014.06.001_bb0070","doi-asserted-by":"crossref","first-page":"e5008","DOI":"10.1136\/bmj.e5008","article-title":"Pertussis cases rise 10-fold among older children and adults in England and Wales","volume":"345","author":"Kmietowicz","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jim.2014.06.001_bb0075","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3201\/eid2004.131478","article-title":"Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia","volume":"20","author":"Lam","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jim.2014.06.001_bb0080","doi-asserted-by":"crossref","first-page":"e77165","DOI":"10.1371\/journal.pone.0077165","article-title":"Genetic analysis of Bordetella pertussis isolates from the 2008\u20132010 pertussis epidemic in Japan","volume":"8","author":"Miyaji","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2014.06.001_bb0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/CVI.00717-13","article-title":"Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States","volume":"21","author":"Pawloski","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jim.2014.06.001_bb0090","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1128\/IAI.58.10.3369-3374.1990","article-title":"Protective activities in mice of monoclonal antibodies against pertussis toxin","volume":"58","author":"Sato","year":"1990","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2014.06.001_bb0095","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1128\/JCM.43.5.2449-2451.2005","article-title":"Use of monoclonal antibodies to serotype Bordetella pertussis isolates: comparison of results obtained by indirect whole-cell enzyme-linked immunosorbent assay and bacterial microagglutination methods","volume":"43","author":"Tsang","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2014.06.001_bb0100","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1016\/j.vaccine.2013.07.060","article-title":"Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?","volume":"31","author":"van der Maas","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2014.06.001_bb0105","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jpeds.2012.05.041","article-title":"California pertussis epidemic, 2010","volume":"161","author":"Winter","year":"2012","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jim.2014.06.001_bb0110","series-title":"International Collaborative Study: Evaluation of Proposed International Standard Monoclonal Antibodies for Serotyping Bordetella pertussis Fimbrial Antigen 2 and Fimbrial Antigen 3","author":"Xing","year":"2009"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175914001835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175914001835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T20:09:41Z","timestamp":1597954181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175914001835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":22,"alternative-id":["S0022175914001835"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2014.06.001","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2014.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}